ExPLoRNA Therapeutics receives funding to advance its new mRNA technology
Funding from the Bill & Melinda Gates Foundation will help realize the utility of a novel cap analog for medical applications. WARSAW, Poland, December 8, 2022 /PRNewswire/ — ExPLoRNA Therapeutics, a Polish biotech company, has received funding from the Bill & Melinda Gates Foundation to further advance its unique mRNA technology, transforming mRNA vaccines and … Read more